Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rtunorm is an oral phytomedicine developed by Juvenor Pharmaceuticals and marketed in partnership with Piramal Enterprises. It is specifically formulated for the management of menstrual disorders, including irregular menstrual cycles, dysmenorrhea (painful menstruation), and polycystic ovary syndrome (PCOS). As a phytomedicine, Rtunorm utilizes a standardized blend of botanical extracts that act as uterine tonics and hormonal regulators. The therapeutic mechanism involves the modulation of the hypothalamic-pituitary-ovarian (HPO) axis to restore hormonal balance and regulate ovulation. Additionally, the formulation provides antispasmodic and anti-inflammatory effects, which help alleviate the physical discomfort associated with menstrual irregularities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Rtunorm.